Huixia Lu

2.6k total citations · 1 hit paper
76 papers, 1.8k citations indexed

About

Huixia Lu is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Huixia Lu has authored 76 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cardiology and Cardiovascular Medicine, 21 papers in Molecular Biology and 15 papers in Epidemiology. Recurrent topics in Huixia Lu's work include Cardiovascular Function and Risk Factors (13 papers), Heart Failure Treatment and Management (12 papers) and Ginseng Biological Effects and Applications (5 papers). Huixia Lu is often cited by papers focused on Cardiovascular Function and Risk Factors (13 papers), Heart Failure Treatment and Management (12 papers) and Ginseng Biological Effects and Applications (5 papers). Huixia Lu collaborates with scholars based in China, Thailand and Bangladesh. Huixia Lu's co-authors include Yun Zhang, Chuanzhu Yan, Peiyan Shan, Wei Wu, Liang Guo, Kunqian Ji, Kaiming Liu, Wenqiang Chen, Cheng Zhang and Huili Lin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Circulation Research.

In The Last Decade

Huixia Lu

70 papers receiving 1.8k citations

Hit Papers

LAMP2A, LAMP2B and LAMP2C: similar structures, divergent ... 2023 2026 2024 2025 2023 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. LAMP2A, LAMP2B and LAMP2C: similar structures, divergent roles
    2023 81 citations Huixia Lu, Wenqiang Chen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huixia Lu China 21 815 435 342 318 246 76 1.8k
Wenjun Yan China 24 1.0k 1.2× 447 1.0× 350 1.0× 462 1.5× 283 1.2× 46 1.9k
Hala O. El‐Mesallamy Egypt 27 689 0.8× 388 0.9× 152 0.4× 275 0.9× 268 1.1× 78 1.8k
Hongmei Tan China 22 1.1k 1.4× 231 0.5× 334 1.0× 211 0.7× 270 1.1× 37 2.1k
Sung Kwang Park South Korea 24 935 1.1× 231 0.5× 408 1.2× 223 0.7× 236 1.0× 62 2.3k
Narasimman Gurusamy United States 29 1.0k 1.3× 489 1.1× 495 1.4× 305 1.0× 247 1.0× 64 2.3k
Subat Turdi United States 26 700 0.9× 442 1.0× 425 1.2× 364 1.1× 166 0.7× 37 1.6k
Zhaoyun Zhang China 28 539 0.7× 451 1.0× 279 0.8× 515 1.6× 533 2.2× 111 2.6k
Kyung Pyo Kang South Korea 28 804 1.0× 269 0.6× 250 0.7× 313 1.0× 310 1.3× 100 2.5k
Wenhui Peng China 23 593 0.7× 249 0.6× 372 1.1× 200 0.6× 197 0.8× 71 1.5k

Countries citing papers authored by Huixia Lu

Since Specialization
Citations

This map shows the geographic impact of Huixia Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huixia Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huixia Lu more than expected).

Fields of papers citing papers by Huixia Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huixia Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huixia Lu. The network helps show where Huixia Lu may publish in the future.

Co-authorship network of co-authors of Huixia Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Huixia Lu. A scholar is included among the top collaborators of Huixia Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huixia Lu. Huixia Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fan, Cuiqin, Han Du, Huixia Lu, et al.. (2025). PIEZO1 gain-of-function mutation drives cardiomyopathy by disrupting myocardial lipid homeostasis besides iron overload. Science Advances. 11(46). eady9242–eady9242.
2.
Luo, Yijie, Kang Fu, Xinyu Zhang, et al.. (2024). The triglyceride-to-high-density lipoprotein cholesterol ratio is associated with an increased risk of peripartum cardiomyopathy. Frontiers in Endocrinology. 15. 1447791–1447791. 1 indexed citations
3.
Dong, Mei, Guihua Zhang, Yanling Zhang, et al.. (2024). Vericiguat in heart failure with reduced ejection fraction patients on guideline-directed medical therapy: Insights from a 6-month real-world study. International Journal of Cardiology. 417. 132524–132524. 2 indexed citations
4.
Zhang, Yanling, et al.. (2024). Sex Differences in the Impact of Frailty on Patients with Heart Failure: A Retrospective Cohort Study. ESC Heart Failure. 11(6). 4092–4103. 4 indexed citations
5.
Wei, Changjiang, et al.. (2024). Novel Adiposity Indices Are Associated With Poor Prognosis in Heart Failure With Preserved Ejection Fraction Without the Obesity Paradox. Journal of the American Heart Association. 13(22). e035430–e035430. 5 indexed citations
6.
7.
Wang, Chen, Zongwei Lin, Hui Zhang, et al.. (2023). Dose Titration of Sacubitril/Valsartan for Heart Failure with Reduced Ejection Fraction: A Real-World Study. ESC Heart Failure. 10(3). 1961–1971. 11 indexed citations
8.
Lin, Zongwei, Hui Zhang, Rui Tang, et al.. (2023). Efficacy and safety of sacubitril/valsartan after six months in patients with heart failure with reduced ejection fraction and asymptomatic hypotension. Journal of Geriatric Cardiology. 20(12). 855–866. 2 indexed citations
9.
Zhang, Xinyu, Yijun Sun, Ying Li, et al.. (2023). Association between visceral adiposity index and heart failure: A cross‐sectional study. Clinical Cardiology. 46(3). 310–319. 31 indexed citations
10.
Zhou, Xiaoying, Huixia Lu, Shanhu Qiu, et al.. (2023). Impaired antibody response to inactivated COVID-19 vaccines in hospitalized patients with type 2 diabetes. Human Vaccines & Immunotherapeutics. 19(1). 2184754–2184754. 10 indexed citations
11.
Li, Yongming, et al.. (2019). Effects of Luo Han Guo on throat complications associated with tracheal intubation: a randomized controlled trial. Journal of International Medical Research. 47(7). 3203–3211. 4 indexed citations
12.
Tian, Mi, Ping Hu, Jianmin Yang, et al.. (2019). Smooth muscle-specific Gsα deletion exaggerates angiotensin II-induced abdominal aortic aneurysm formation in mice in vivo. Journal of Molecular and Cellular Cardiology. 132. 49–59. 26 indexed citations
13.
Guo, Rong, et al.. (2018). Contribution of TLR4 signaling in intermittent hypoxia-mediated atherosclerosis progression. Journal of Translational Medicine. 16(1). 106–106. 45 indexed citations
14.
15.
16.
Liu, Fukang, Zhixiu Song, Huixia Lu, et al.. (2015). Practical Application of Antidiabetic Efficacy of <i>Lycium barbarum</i> Polysaccharide in Patients with Type 2 Diabetes. Medicinal Chemistry. 11(4). 383–390. 96 indexed citations
17.
Li, Xiaonan, et al.. (2009). Effect of metoprolol on vulnerable plaque in rabbits by changing shear stress around plaque and reducing inflammation. European Journal of Pharmacology. 613(1-3). 79–85. 20 indexed citations
18.
Lu, Huixia, Guihua Yao, Huili Lin, et al.. (2008). Transmural Peak Systolic Strain and Strain Rate Predict Transmural Myocardial Blood Flow in a Pig Myocardial Infarction Model. Cardiology. 112(2). 122–128. 1 indexed citations
19.
Lu, Huixia, Mei Zhang, Renhai Cao, et al.. (2007). Combinatorial protein therapy of angiogenic and arteriogenic factors remarkably improves collaterogenesis and cardiac function in pigs. Proceedings of the National Academy of Sciences. 104(29). 12140–12145. 77 indexed citations
20.
Lin, Huili, Huixia Lu, Lei Zhang, et al.. (2007). Pathological mechanisms and dose dependency of erythrocyte-induced vulnerability of atherosclerotic plaques. Journal of Molecular and Cellular Cardiology. 43(3). 272–280. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenjun Yan Breakdown of academic impact, for papers by Hala O. El‐Mesallamy Breakdown of academic impact, for papers by Hongmei Tan Breakdown of academic impact, for papers by Sung Kwang Park Breakdown of academic impact, for papers by Narasimman Gurusamy Breakdown of academic impact, for papers by Subat Turdi Breakdown of academic impact, for papers by Zhaoyun Zhang Breakdown of academic impact, for papers by Kyung Pyo Kang Breakdown of academic impact, for papers by Wenhui Peng
Rankless by CCL
2026